American Journal of Respiratory and Critical Care Medicine Vol 165. pp. 1384-1387, (2002)
© 2002 American Thoracic Society
High Concentrations of Keratinocyte Growth Factor in Airways of Premature Infants Predicted Absence of Bronchopulmonary Dysplasia
Claude Danan,
Marie-Laure Franco,
Pierre-Henri Jarreau,
Gilles Dassieu,
Bernadette Chailley-Heu,
Jacques Bourbon and
Christophe Delacourt
Unité de réanimation néonatale, Centre Hospitalier Intercommunal de Créteil, Créteil; Service de Réanimation néonatale, Hôpital Cochin-Port Royal, Paris; and INSERM U492, Faculté de Médecine de Créteil, Créteil, France
Correspondence and requests for reprints should be addressed to Christophe Delacourt, Service de Pédiatrie, Centre Hospitalier Intercommunal de Créteil, 40 avenue de Verdun, 94000 Créteil, France. E-mail: christophe.delacourt{at}chicreteil.fr
Premature lungs are highly susceptible to lung injuries, leading to bronchopulmonary dysplasia (BPD). Keratinocyte growth factor (KGF) is produced by the developing lung and may reduce the risk of BPD by preventing injury to the lung epithelium and enhancing its repair. To determine whether KGF concentrations in the airways during the initial phase of hyaline membrane disease are correlated with subsequent development of BPD defined as the need for supplemental oxygen at a postconceptional age of 36 weeks, we obtained tracheal aspirates within 3 hours of birth (Day 0) from 91 intubated neonates with a gestational age of 30 weeks or less. Repeat samples were obtained from 42 neonates within 5 days after birth. KGF in aspirate supernatants was measured by enzyme-linked immunosorbent assay. On Day 0, KGF was detected in all but six neonates. A significant increase in KGF concentration was found from the first to the second samples. The highest KGF concentration within 5 days after birth (KGFmax) was significantly higher in survivors without BPD than in those with BPD. A KGFmax value higher than 110 pg/ml had a positive predictive value of 95% for absence of BPD. KGF may hold promise for the treatment of very premature neonates.
Key Words: lung development newborn bronchopulmonary dysplasia
This article has been cited by other articles:

|
 |

|
 |
 
M.-L. Franco-Montoya, J. R. Bourbon, X. Durrmeyer, S. Lorotte, P.-H. Jarreau, and C. Delacourt
Pulmonary effects of keratinocyte growth factor in newborn rats exposed to hyperoxia
Am J Physiol Lung Cell Mol Physiol,
November 1, 2009;
297(5):
L965 - L976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bhandari and V. Bhandari
Pitfalls, Problems, and Progress in Bronchopulmonary Dysplasia
Pediatrics,
June 1, 2009;
123(6):
1562 - 1573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Plantier, S. Marchand-Adam, V. G. Antico, L. Boyer, C. De Coster, J. Marchal, R. Bachoual, A. Mailleux, J. Boczkowski, and B. Crestani
Keratinocyte growth factor protects against elastase-induced pulmonary emphysema in mice
Am J Physiol Lung Cell Mol Physiol,
November 1, 2007;
293(5):
L1230 - L1239.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Plantier, S. Marchand-Adam, J. Marchal-Somme, G. Leseche, M. Fournier, M. Dehoux, M. Aubier, and B. Crestani
Defect of hepatocyte growth factor production by fibroblasts in human pulmonary emphysema
Am J Physiol Lung Cell Mol Physiol,
April 1, 2005;
288(4):
L641 - L647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Christou and D. Brodsky
Lung Injury and Bronchopulmonary Dysplasia in Newborn Infants
J Intensive Care Med,
March 1, 2005;
20(2):
76 - 87.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-N. Tsao, S.-C. Wei, Y.-N. Su, C.-N. Lee, H.-C. Chou, W.-S. Hsieh, and F.-J. Hsieh
Placenta Growth Factor Elevation in the Cord Blood of Premature Neonates Predicts Poor Pulmonary Outcome
Pediatrics,
May 1, 2004;
113(5):
1348 - 1351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Fehrenbach, C. Bube, J. M. Hohlfeld, P. Stevens, T. Tschernig, H. G. Hoymann, N. Krug, and H. Fehrenbach
Surfactant Homeostasis Is Maintained In Vivo during Keratinocyte Growth Factor-induced Rat Lung Type II Cell Hyperplasia
Am. J. Respir. Crit. Care Med.,
May 1, 2003;
167(9):
1264 - 1270.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2002
Am. J. Respir. Crit. Care Med.,
February 1, 2003;
167(3):
333 - 344.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Danan, P.-H. Jarreau, M.-L. Franco, G. Dassieu, C. Grillon, I. A. Alsamad, C. Lafuma, A. Harf, and C. Delacourt
Gelatinase activities in the airways of premature infants and development of bronchopulmonary dysplasia
Am J Physiol Lung Cell Mol Physiol,
November 1, 2002;
283(5):
L1086 - L1093.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 American Thoracic Society
|
|
|